Skip to main navigation
Skip to search
Skip to main content
University of Johannesburg Home
Search content at University of Johannesburg
Home
Scholars
Research entities
Research output
Press/Media
Equipment & facilities
Prestigious awards
Gene therapy as a new emerging strategy for prostate cancer
Samaneh Adelian
, Amin Soltani
,
Michael R. Hamblin
Laser Research Centre
Shahrekord University of Medical Sciences
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gene therapy as a new emerging strategy for prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Prostate Cancer
100%
Gene Therapy
100%
Clustered Regularly Interspaced Short Palindromic Repeat
40%
Cas9
40%
Immune Response
40%
Clinical Trial
40%
Malignant Neoplasm
20%
Chimeric Antigen Receptor T-Cell
20%
Neoplasm
20%
Tumor Antigen
20%
Genome Editing
20%
Diseases
20%
Immune System
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Clinical Trial
66%
Malignant Neoplasm
33%
Neoplasm
33%
Tumor Antigen
33%
Chimeric Antigen Receptor
33%
Diseases
33%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
CRISPR/Cas9
40%
Clinical Trial
40%
Immune Response
40%
Genome Editing
20%
Chimeric Antigen Receptor
20%
T Cell
20%
Tumor Antigen
20%
Keyphrases
Gene Modification
20%
Thera
20%
Anatomical Considerations
20%